Trial Profile
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Influenza-immune-globulin-Emergent-BioSolutions (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Therapeutic Use
- Acronyms INSIGHT 005
- 02 Nov 2017 New trial record